Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Mannitol in Individuals With Cough Variant Asthma and Chronic Cough

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test, Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

The objectives of this study are to determine the sensory-mechanical responses to Eucapneic Voluntary Hyperventilation (EVH) and Mannitol in individuals with cough variant asthma (CVA) and methacholine-induced cough with normal airway sensitivity (COUGH) and compare these responses to a control group of healthy individuals without asthma or chronic cough. We hypothesize: 1. EVH and Mannitol cause dyspnea, cough, small airway obstruction with resultant dynamic hyperinflation, gas trapping and autoPEEP in individuals with CVA and COUGH, but not healthy controls. 2. The sensory-mechanical responses to both hyperosmolar challenges (EVH and Mannitol) are comparable within groups (CVA, COUGH and healthy controls).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: t
View:

• Individuals aged 18-65 years of age with CVA and individuals with methacholine-induced cough but normal airway sensitivity. The following definitions will be used:

‣ CVA: chronic cough (≥8 weeks) is the sole or predominant symptom and positive methacholine challenge (PC20 ≤ 16 mg/mL) and history of cough responding to specific asthma treatment (such as inhaled steroid or 1 week trial of bronchodilator);

⁃ Methacholine-induced cough but normal airway sensitivity: chronic cough (≥8 weeks) is the sole or predominant symptom and negative methacholine challenges (PC20 \> 16 mg/mL).

• Individuals aged 18-65 years of age with no history of asthma or chronic cough.

Locations
Other Locations
Canada
Kingston Health Sciences Centre
RECRUITING
Kingston
Contact Information
Primary
M. Diane Lougheed, MD, MSc
diane.lougheed@kingstonhsc.ca
613-548-2348
Backup
Taylar Wall, RRT
taylar.wall@kingstonhsc.ca
613-549-6666
Time Frame
Start Date: 2022-03-01
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 30
Treatments
Experimental: Cough Variant Asthma
Individuals diagnosed with Cough variant asthma
Experimental: Methacholine-induced cough
Individuals with chronic cough and negative methacholine challenge
Experimental: Control
Individuals with no history of asthma or chronic cough
Related Therapeutic Areas
Sponsors
Leads: Dr. Diane Lougheed

This content was sourced from clinicaltrials.gov